We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Automated Specialty Panels Test for Bacteria

By Labmedica staff writers
Posted on 02 Jan 2008
New instruments offer simultaneous automation of overnight, rapid, and specialty panels that test for both gram-negative and gram-positive bacteria. More...
The instruments are suitable for mid- and high-volume clinical diagnostic microbiology laboratories.

MicroScan technology was introduced as an advanced technology based on the microbiology principles of true minimum inhibitory concentration (MIC) testing. This principle is a very sensitive method to determine bacteria's susceptibility to antibiotics. The new WalkAway plus Systems combine MIC technology with new automated features, including automated maintenance and dial-up system diagnostics capability.

Launched by Siemens Medical Solutions (Deerfield, IL, USA) the new WalkAway plus systems also offer advanced automation features that improve laboratory productivity by decreasing system maintenance activity. The two new instrument models, a 40-panel capacity model for medium-volume laboratories and a 96-panel capacity model for high-volume laboratories, replace the current WalkAway SI 40 and 96 Systems.

Siemens Medical Solutions Diagnostics has nearly 60 MicroScan panels of tests, with up-to-date antibiotics including the overnight, rapid, and specialty panels. The company was the first to offer an automated identification and susceptibility testing system cleared for improved detection of the emerging resistant bacterium vancomycin-resistant Staphylococcus aureus (VRSA).

"We remain committed to addressing the challenges of today's clinical laboratory,” said Jim Reid-Anderson, president and CEO, Siemens Medical Solutions Diagnostics. "This new innovation for the microbiology laboratory allows customers to improve laboratory workflow and productivity while helping them to continue advancing the quality of patient care in their facilities.”

Siemens Medical Solutions provides medical solutions with core competence and innovative strength in diagnostic and therapeutic technologies. With its laboratory diagnostics acquisitions, Siemens Medical Solutions combines lab diagnostics, imaging, therapy, and healthcare information technology solutions, supplemented by consulting and support services.


Related Links:
Siemens Medical Solutions

New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
New
Sample Transportation System
Tempus1800 Necto
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.